Edition:
India

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

1,380.00INR
12:46pm IST
Change (% chg)

Rs18.05 (+1.33%)
Prev Close
Rs1,361.95
Open
Rs1,361.10
Day's High
Rs1,386.95
Day's Low
Rs1,358.15
Volume
10,848
Avg. Vol
41,465
52-wk High
Rs1,520.00
52-wk Low
Rs1,130.00

Latest Key Developments (Source: Significant Developments)

Glaxosmithkline Pharmaceuticals Recalls Zinetac Tablets Manufactured In India
Wednesday, 25 Sep 2019 

Sept 25 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd ::CONTACTED BY REGULATORY AUTHORITIES ABOUT DETECTION OF NDMA IN RANITIDINE PRODUCTS.SUSPENDS DISTRIBUTION OF ALL DOSE FORMS OF RANITIDINE HYDROCHLORIDE PRODUCTS TO ALL MARKETS.SUSPENSION AS A PRECAUTIONARY ACTION PENDING OUTCOME OF ONGOING TESTS AND INVESTIGATIONS.INITIATES VOLUNTARY RECALL OF ZINETAC TABLETS 150 MG AND 300 MG PRODUCTS MANUFACTURED IN INDIA.PRODUCT MANUFACTURED USING API FROM SMS LIFESCIENCES INDIA REMAIN ON HOLD, WILL NOT BE RELEASED WHILE CO AWAITS TEST RESULTS.  Full Article

India's Glaxosmithkline Pharma Sells Company Land In Western India
Friday, 30 Aug 2019 

Aug 30 (Reuters) - India's Glaxosmithkline Pharmaceuticals Ltd ::INFORMS EXCHANGES ABOUT APPROVAL OF SALE OF COMPANY LAND AT THANE IN W. INDIA.SAYS SOLD LAND TO OBEROI REALTY LIMITED FOR 8.9 BILLION RUPEES.  Full Article

Glaxosmithkline Pharmaceuticals Sells Land to Oberoi Realty
Friday, 30 Aug 2019 

Aug 30 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd ::SALE IN FAVOUR OF OBEROI REALTY LIMITED FOR A TOTAL CONSIDERATION OF 8.9 BILLION RUPEES.APPROVAL OF SALE OF COMPANY'S LAND AT THANE, MAHARASHTRA.  Full Article

India's Glaxosmithkline Pharmaceuticals June Qtr Consol Profit Rises
Monday, 22 Jul 2019 

July 22 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd ::JUNE QUARTER CONSOL PROFIT 1.14 BILLION RUPEES VERSUS PROFIT 840.8 MILLION RUPEES YEAR AGO.JUNE QUARTER CONSOL REVENUE FROM OPERATIONS 7.88 BILLION RUPEES VERSUS 7.36 BILLION RUPEES YEAR AGO.  Full Article

India's Glaxosmithkline Pharmaceuticals March-Qtr Profit Rises
Monday, 20 May 2019 

May 20 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd ::MARCH QUARTER PROFIT 1.23 BILLION RUPEES VERSUS PROFIT 1.06 BILLION RUPEES YEAR AGO.MARCH QUARTER REVENUE FROM OPERATIONS 7.51 BILLION RUPEES VERSUS 7.49 BILLION RUPEES YEAR AGO.RECOMMENDED DIVIDEND OF 20 RUPEES PER SHARE.  Full Article

Glaxosmithkline Pharmaceuticals Approves Resignation Of Deepak Parekh As Chairman
Thursday, 28 Mar 2019 

March 28 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd ::APPROVES RESIGNATION OF DEEPAK PAREKH AS NON- EXECUTIVE DIRECTOR AND CHAIRMAN OF CO.APPROVES APPOINTMENT OF RENU SUD KARNAD AS NON-EXECUTIVE, NON-RETIRING DIRECTOR AND CHAIRPERSON OF CO.  Full Article

India's Glaxosmithkline Pharmaceuticals Dec Qtr Profit Rises
Monday, 4 Feb 2019 

Feb 4 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd ::DEC QUARTER PROFIT 1.13 BILLION RUPEES VERSUS PROFIT 896.9 MLN RUPEES YEAR AGO.DEC QUARTER REVENUE FROM OPERATIONS 8.25 BILLION RUPEES VERSUS 7.04 BILLION RUPEES YEAR AGO.GLAXOSMITHKLINE PHARMACEUTICALS LTD - RE-APPOINTED ANNASWAMY VAIDHEESH AS MANAGING DIRECTOR FROM 1ST OCTOBER, 2019 TO 31ST MARCH 2020.  Full Article

India's Glaxosmithkline Pharmaceuticals Sept Qtr Profit Falls
Monday, 22 Oct 2018 

Oct 22 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd ::SEPT QUARTER PROFIT 1.01 BILLION RUPEES VERSUS PROFIT 1.30 BILLION RUPEES YEAR AGO.SEPT QUARTER REVENUE FROM OPERATIONS 8.16 BILLION RUPEES VERSUS 8.36 BILLION RUPEES YEAR AGO.  Full Article

Glaxosmithkline Pharmaceuticals June-Qtr Profit Jumps
Tuesday, 24 Jul 2018 

July 24 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd ::JUNE QUARTER PROFIT 885.9 MILLION RUPEES VERSUS PROFIT OF 264.2 MILLION RUPEES YEAR AGO.JUNE QUARTER REVENUE FROM OPERATIONS 7.36 BILLION RUPEES VERSUS 6.07 BILLION RUPEES YEAR AGO.GLAXOSMITHKLINE PHARMACEUTICALS LTD - APPROVED BONUS ISSUE OF 1:1 RATIO.SAYS EXCEPTIONAL CHARGE OF 82.8 MILLION RUPEES IN JUNE-QUARTER.  Full Article

India's Glaxosmithkline Pharmaceuticals March Qtr Profit Falls
Thursday, 24 May 2018 

May 24 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd ::MARCH QUARTER PROFIT 1.06 BILLION RUPEES VERSUS PROFIT 1.13 BILLION RUPEES YEAR AGO.MARCH QUARTER REVENUE FROM OPERATIONS 7.49 BILLION RUPEES VERSUS 7.84 BILLION RUPEES YEAR AGO.RECOMMENDED DIVIDEND OF 35 RUPEES PER SHARE.  Full Article